Every drug works because of its chemistry — the specific atoms, bonds, and three-dimensional shape that determine how it binds to a receptor, how long it stays in the body, and what side effects it causes. Medicinal Chemistry I is the B Pharma 4th semester subject where this chemistry first becomes systematic — covering the physicochemical basis of drug action, structure-activity relationships (SAR), drug metabolism pathways, and the detailed chemistry of drugs acting on the autonomic and central nervous systems.
These Medicinal Chemistry I notes are prepared as per the PCI-approved B Pharma 4th semester syllabus 2025–26, structured unit-wise from drug design fundamentals and Phase I/II metabolism through adrenergic, cholinergic, CNS, and analgesic drug chemistry. Each unit download has a clear topic summary. Med Chem I is one of the highest-weightage GPAT subjects — QSAR principles, prodrug design, bioisosterism, SAR of adrenergic and cholinergic drugs, benzodiazepine and barbiturate chemistry, and opioid SAR appear in virtually every GPAT paper.
Download Medicinal Chemistry I Notes PDF – Unit Wise
Click below to download free PDFs for each unit:
Course Units
Unit 1: Medicinal Chemistry Overview
Topics Covered: the introduction, history, physicochemical properties influencing drug action, stereochemistry, and detailed principles of drug metabolism including Phase I and Phase II pathways.
Unit 2: Adrenergic Nervous System Drugs
Topics Covered: Includes biosynthesis and breakdown of catecholamines, adrenergic receptors, SAR of sympathomimetic agents, indirect and mixed-acting adrenergic drugs, and alpha/beta adrenergic antagonists.
Unit 3: Cholinergic Nervous System Drugs
Topics Covered: Explains acetylcholine biosynthesis and degradation, cholinergic receptor distribution, SAR of parasympathomimetic agents, cholinesterase inhibitors and reactivators, and muscarinic/nicotinic blocking drugs.
Unit 4: CNS Drugs: Sedatives, Hypnotics, Antipsychotics & Anticonvulsants
Topics Covered: SAR and classification of sedatives-hypnotics, benzodiazepines, barbiturates, antipsychotic drug classes, and major anticonvulsants with mechanisms of action.
Unit 5: CNS Drugs: Anesthetics, Analgesics & Anti-inflammatory Agents
Topics Covered: Includes general and dissociative anesthetics, opioid and non-opioid analgesics with SAR, narcotic antagonists, and a broad range of anti-inflammatory drugs.
What is Medicinal Chemistry I?
Medicinal Chemistry I deals with the chemical basis of drug action, including how the structure, functional groups, stereochemistry, and physicochemical properties of drug molecules influence their activity.
It also covers structure–activity relationships (SARs), mechanisms of action, and the chemistry of important therapeutic drug classes.
These notes will help you understand topics like:
Drug Design & Development:
Lead compound discovery
Bioisosterism
Prodrugs
Physicochemical properties of drugs
Drug-receptor interactions
QSAR (Qualitative & Quantitative SAR)
Drug Metabolism:
Phase I & Phase II reactions
Enzymes involved in biotransformation
Oxidation, reduction, hydrolysis, conjugation reactions
Importance of metabolism in drug design
Drugs Acting on the Autonomic Nervous System:
Cholinergic drugs: agonists, antagonists, anticholinesterases
Adrenergic drugs: sympathomimetics, blockers
Ganglionic stimulants/blockers
Neuromuscular blockers
Includes structures, IUPAC names, SAR, and mechanisms
Drugs Acting on the Central Nervous System:
Sedatives & hypnotics
Antipsychotics
Antidepressants
Anticonvulsants
Analgesics
Detailed classification, SAR, and mechanisms for each category
Local Anesthetics:
Ester & amide anesthetics
Mechanism of nerve blockade
SAR: lipophilic group, intermediate chain, ionizable group
Diuretics:
Carbonic anhydrase inhibitors
Thiazides
Loop diuretics
Potassium-sparing diuretics
Includes SAR and chemical classes
Antihistamines:
H1 antihistamines (1st & 2nd generation)
SAR and classification
Frequently Asked Questions (FAQ)
Q1. What is QSAR in medicinal chemistry?
QSAR (Quantitative Structure-Activity Relationship) is a mathematical method that correlates the chemical structure of drug molecules with their biological activity using physicochemical descriptors. It is used in drug design to predict the activity of new compounds without synthesising every possible molecule. QSAR is a standard GPAT topic covered in Unit 1.
Q2. What is bioisosterism in drug design?
Bioisosterism is the replacement of an atom or group of atoms in a drug molecule with another atom or group (bioisostere) that has similar physicochemical properties — without significantly changing the drug’s biological activity. It is used to improve pharmacokinetic properties, reduce toxicity, or circumvent patent restrictions. Classic examples include replacing -OH with -NH2 or -F with -H. Covered in Unit 1.
Q3. What is the difference between Phase I and Phase II drug metabolism?
Phase I metabolism involves oxidation, reduction, and hydrolysis reactions that typically introduce or expose a functional group — making the drug more polar. Phase II metabolism involves conjugation reactions (glucuronidation, sulfation, acetylation, methylation) that attach a polar molecule to the drug, making it water-soluble for excretion. Phase I reactions usually precede Phase II. Both are covered in Unit 1 with detailed enzyme-level mechanisms.
Q4. What is a prodrug and why is it used?
A prodrug is a pharmacologically inactive compound that is converted into an active drug inside the body through metabolic processes. Prodrugs are designed to overcome problems like poor oral bioavailability, instability, unpleasant taste, or toxic effects of the active drug. Examples include enalapril (converted to enalaprilat), levodopa (converted to dopamine), and codeine (converted to morphine). Covered in Unit 1 under drug design principles.